Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

Cidara Therapeutics (CDTX) announced it has reached full planned enrollment of 5,000 subjects in the Phase 2b NAVIGATE trial across clinical ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...

But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

With Sunday marking the 37th annual World AIDS Day, the Michigan Department of Health and Human Services (DHHS) released its ...

PrEP, or pre-exposure prophylaxis, refers to the use of antiviral drugs to prevent people exposed to HIV from becoming ...

On Worlds AIDS Day, the benefits of PEPFAR, PrEP, and U=U are celebrated. But continuing stigma and decreasing political will ...